Exact Mass: 259.0207844
Exact Mass Matches: 259.0207844
Found 353 metabolites which its exact mass value is equals to given mass value 259.0207844
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Glucosamine 6-phosphate
C6H14NO8P (259.04570140000004)
Glucosamine 6-phosphate (CAS: 3616-42-0) is normally produced in endothelial cells via de novo glucosamine synthesis by the enzyme fructose-6-phosphate amidotransferase and the modulation of this pathway by hyperglycemia and glutamine. Glutamine-fructose-6-phosphate amidotransferase (GFAT) catalyzes the first committed step in the pathway for biosynthesis of hexosamines in mammals.It is a member of the N-terminal nucleophile class of amidotransferases, GFAT transfers the amino group from the L-glutamine amide to D-fructose 6-phosphate, producing glutamic acid and glucosamine 6-phosphate. As glucosamine inhibits endothelial nitric oxide synthesis it has important implications for impaired endothelium-dependent relaxation and vascular dysfunction in diabetes mellitus (PMID:11270676, 11842094). Glucosamine 6-phosphate is normally produced in endothelial cells via the de novo glucosamine synthesis by the enzyme fructose-6-phosphate amidotransferase and the modulation of this pathway by hyperglycemia and glutamine. glutamine-fructose-6-phosphate amidotransferase (GFAT) catalyzes the first committed step in the pathway for biosynthesis of hexosamines in mammals. A member of the N-terminal nucleophile class of amidotransferases, GFAT transfers the amino group from the L-glutamine amide to D-fructose 6-phosphate, producing glutamic acid and glucosamine 6-phosphate. As glucosamine inhibits endothelial nitric oxide synthesis it has important implications for impaired endothelium-dependent relaxation and vascular dysfunction in diabetes mellitus. (PMID 11270676, 11842094) [HMDB] Acquisition and generation of the data is financially supported in part by CREST/JST. KEIO_ID G021; [MS2] KO008968 KEIO_ID G021
Glucosamine-1P
C6H14NO8P (259.04570140000004)
Glucosamine-1P is a substrate of enzyme UDP-N-acetylglucosamine diphosphorylase [EC 2.7.7.23] (KEGG). [HMDB] Glucosamine-1P is a substrate of enzyme UDP-N-acetylglucosamine diphosphorylase [EC 2.7.7.23] (KEGG). KEIO_ID G065
N-Sulfo-D-glucosamine
N-Sulfo-D-glucosamine is a structurally altered form of N-acetyl-D-glucosamine (a polysaccharide found in animal tissues) by heparan sulfate N-deacetylase /N-sulfotransferase enzymes. No human references found [HMDB]
scyllo-Inosamine 4-phosphate
C6H14NO8P (259.04570140000004)
Kanosamine 6-phosphate
C6H14NO8P (259.04570140000004)
Aminofructose 6-phosphate
C6H14NO8P (259.04570140000004)
This compound belongs to the family of Pentose Phosphates. These are carbohydrate derivatives containing a pentose substituted by one or more phosphate groups.
Arminum
D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D002800 - Cholinesterase Inhibitors D004791 - Enzyme Inhibitors Same as: D01591
Vinclozolin M2
C11H11Cl2NO2 (259.01668060000003)
3-Bromotyrosine
3-Bromotyrosine(BY) is generated from the halogenation of tyrosine residues in plasma proteins via the enzyme Eosinophil peroxidase. The presence of free bromotyrosine in blood or urine is the result of enzymatic degradation of these brominated proteins. A significantly higher concentration of BY was observed in the urine from asthmatic patients than in that from healthy control subjects (PMID: 15196282). Bromotyrosine may be useful for monitoring the activation of eosinophils in asthmatic patients. 3-Bromotyrosine(BY) is generated from the halogenation of tyrosine residues in plasma proteins via the enzyme Eosinophil peroxidase. A significantly higher concentration of BY was observed in the urine from asthmatic patients than in that from healthy control subjects (PMID: 15196282). [HMDB]
D-Galactosamine 6-phosphate
C6H14NO8P (259.04570140000004)
A galactosamine phosphate that is D-galactosamine substituted at position 1 by a monophosphate group.
Glucosamine 6-sulfate
Glucosamine 6-sulfate is a naturally occurring compound present in many of the bodys tissues, and belongs to a class of compounds known as glycosaminoglycans (GAGs). Glucosamine 6-sulfate is being used in the treatment of arthritis. Glucosamine for arthritis products is usually formulated as the hydrochloride salt or glucosamine sulfate and often combined with chondroitin sulphate. It is notable that while both the hydrochloride salt and glucosamine sulfate are used in pharmaceutical preparations, glucosamine sulfate is thought to have a higher biological activity due to the presence of the sulfate. It should also be noted that there is a large cost difference between the two salts, with the hydrochloride salt being significantly less expensive. (PMID: 15925239) [HMDB] Glucosamine 6-sulfate is a naturally occurring compound present in many of the bodys tissues, and belongs to a class of compounds known as glycosaminoglycans (GAGs). Glucosamine 6-sulfate is being used in the treatment of arthritis. Glucosamine for arthritis products is usually formulated as the hydrochloride salt or glucosamine sulfate and often combined with chondroitin sulphate. It is notable that while both the hydrochloride salt and glucosamine sulfate are used in pharmaceutical preparations, glucosamine sulfate is thought to have a higher biological activity due to the presence of the sulfate. It should also be noted that there is a large cost difference between the two salts, with the hydrochloride salt being significantly less expensive. (PMID: 15925239).
1-(3-Carboxypropylcarbamoyl)-5-fluorouracil
D-Glucosamine-6-phosphate
C6H14NO8P (259.04570140000004)
Glycerophosphoserine
C6H14NO8P (259.04570140000004)
1-hydroxy-2-methyl-2-(E)-butenyl 4-diphosphate
1-hydroxy-2-methyl-2-(e)-butenyl 4-diphosphate is soluble (in water) and a moderately acidic compound (based on its pKa). 1-hydroxy-2-methyl-2-(e)-butenyl 4-diphosphate can be found in a number of food items such as butternut, pigeon pea, saskatoon berry, and ostrich fern, which makes 1-hydroxy-2-methyl-2-(e)-butenyl 4-diphosphate a potential biomarker for the consumption of these food products.
methyl N-[(3-chlorophenyl)carbamothioyl]carbamimidothioate
2,6-di[(methoxythio)carbonyl]pyridine
C9H9NO4S2 (258.99729940000003)
3-(4-chloro-phenyl)-2-methyl-3,7-dihydro-pyrrolo[2,3-d]pyrimidin-4-one
D-Glucosamine-6-phosphate sodium salt
C6H14NO8P (259.04570140000004)
2-Thiocytidine
2-Thiocytidine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1].
4-Bromo-2,5-dimethoxyphenethylamine
D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D017366 - Serotonin Receptor Agonists D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists
1-METHYL-6,7-DIHYDROXY-1,2,3,4-TETRAHYDROISOQUINOLINE HYDROBROMIDE
1-METHYL-6,7-DIHYDROXY-1,2,3,4-TETRAHYDROISOQUINOLINE
(4-(5-CHLOROTHIOPHEN-2-YL)PHENYL)METHANAMINE HYDROCHLORIDE
2-Dichloromethyl-7-Methyl-3-nitro-imidazo[1,2-a]pyridine
(s)-3-amino-2-oxetanone p-toluenesulfonic acid salt
2-Hydroxy-3-nitro-[1,1-biphenyl]-3-carboxylic acid
2-(2,4-difluorophenyl)-5-(trifluoromethyl)pyridine
METHYL 2-METHOXY-4-[(METHYLSULFONYL)AMINO]-BENZOATE
Azetepa
C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C2842 - DNA Binding Agent
1-(Dichloroacetyl)-1,2,3,4-tetrahydro-6-quinolinol
C11H11Cl2NO2 (259.01668060000003)
2-Butenoic acid,4-[(2,5-dichlorophenyl)amino]-4-oxo-, (Z)- (9CI)
4-(2-AMINO-2-CARBOXYETHYL)BENZO[C]-2,1,3-THIADIAZOLE, HYDROCHLORIDE
C9H10ClN3O2S (259.01822300000003)
ETHYL 5-BROMO-1-METHYL-6-OXO-1,6-DIHYDROPYRIDINE-3-CARBOXYLATE
1-ACETYLINDOLINE-5-SULFONYL CHLORIDE
C10H10ClNO3S (259.00699000000003)
4-CHLORO-2-(2-PYRIDINYL)-6-(TRIFLUOROMETHYL)-PYRIMIDINE
5-(2,4-DICHLORO-BENZYL)-[1,3,4]THIADIAZOL-2-YLAMINE
3,5-bis(methylsulfonyl)benzonitrile
C9H9NO4S2 (258.99729940000003)
6-chloro-3-(trifluoromethyl)pyridine-2-carboximidamide,hydrochloride
C7H6Cl2F3N3 (258.98908520000003)
6,7-DIHYDROXY-1-METHYL-1,2,3,4-TETRAHYDROISOQUINOLINE HYDROBROMIDE
3-[[[2-[(Aminoiminomethyl)amino]-4-thiazolyl]methyl]thio]propanamide
3-chloro-5-(trifluoromethyl)pyridine-2-carboximidamide,hydrochloride
C7H6Cl2F3N3 (258.98908520000003)
2-dimethoxyphosphinothioylsulfanyl-N-(methoxymethyl)acetamide
(+/-)-2-AMINO-6,7-DIHYDROXY-1,2,3,4-TETRAHYDRONAPHTHALENE HBR
2-(4-Aminophenyl)-1,1,1,3,3,3-hexafluoropropan-2-ol
2-amino-6-(trifluoromethyl)benzoic acid, trihydrate
C8H12F3NO5 (259.06675379999996)
2-(2-BROMO-4,5-DIMETHOXYPHENYL)ETHANAMINE HYDROCHLORIDE
3-[2-fluoro-4-(trifluoromethyl)phenyl]pyrrole-2,5-dione
C11H5F4NO2 (259.02563979999996)
ETHYL 2-(5-((ETHOXYCARBONYL)AMINO)-1,2,4-THIADIAZOL-3-YL)ACETATE
methyl 3-bromo-5,6,7,8-tetrahydroimidazo[1,2-a]pyrazine-2-carboxylate
5-[(2-methyl-1-benzofuran-6-yl)methylidene]-1,3-thiazolidine-2,4-dione
4-(2-oxopyrrolidin-1-yl)benzenesulfonyl chloride
C10H10ClNO3S (259.00699000000003)
2,3-Naphthalenediol,6-amino-5,6,7,8-tetrahydro-, hydrobromide (1:1)
4-CHLORO-4-HYDROXY-3-METHOXY-[1,1-BIPHENYL]-3-CARBONITRILE
2-chloro-7-methyl-3-(5-methyl-1,2,4-oxadiazol-3-yl)quinoline
(R)-3-Amino-2-oxetanone p-toluenesulfonic acid salt
4-chloro-6-(4-methoxyphenyl)-7H-pyrrolo[2,3-d]pyrimidine
4-Phenyl-5-(2-thienyl)-4H-1,2,4-triazol-3-ylhydrosulfide
Methyl 2-amino-4-(2-chloroethoxy)-5-methoxybenzoate
6-fluoro-4-(trifluoromethyl)quinoline-2-carboxylic acid
C11H5F4NO2 (259.02563979999996)
3-AMINO-3-(3-BROMO-4-HYDROXY-PHENYL)-PROPIONIC ACID
6-Chloro-3H-spiro[isobenzofuran-1,4-piperidine] hydrochloride
5-Chloro-3H-spiro[isobenzofuran-1,4-piperidine] hydrochloride
3-(2-OXOPYRROLIDIN-1-YL)BENZENE-1-SULFONYL CHLORIDE
C10H10ClNO3S (259.00699000000003)
Ethyl 7-(trifluoromethyl)imidazo[1,2-a]pyrimidine-6-carboxylate
4-oxo-4-[3-(trifluoromethyl)anilino]but-2-enoic acid
4-Chloro-2-(3-pyridinyl)-6-(trifluoromethyl)pyrimidine
3a-(Trifluoromethyl)-3,3a-dihydrobenzo[d]pyrrolo[2,1-b]thiazol-1(2H)-one
azintamide
C78276 - Agent Affecting Digestive System or Metabolism > C66913 - Cholagogues or Choleretic Agents
(Z)-2-(Methoxycarbonylmethoxyimino)-2-(2-aminothiazol-4-yl)acetic acid
C8H9N3O5S (259.02629040000005)
METHYL 3-AMINO-4,5-DIHYDRONAPHTHO[1,2-B]THIOPHENE-2-CARBOXYLATE
C14H13NO2S (259.06669580000005)
2-amino-5-methyl-4-(4-nitrophenyl)thiophene-3-carbonitrile
5-Methyl-2-[(2-nitrophenyl)amino]thiophene-3-carbonitrile
2-(AMINOMETHYL)-5-(4-CHLOROPHENYL)THIOPHENE HYDROCHLORIDE
2-(2,6-DICHLOROPHENOXY)-3-(DIMETHYLAMINO)ACRYLALDEHYDE
C11H11Cl2NO2 (259.01668060000003)
(3-(N,N-dimethylsulfamoyl)-4-Methoxyphenyl)boronic acid
C9H14BNO5S (259.06857040000006)
N-(4-Bromo-1-methyl-1H-pyrazol-5-yl)pivalamide
C9H14BrN3O (259.03201740000003)
Methyl morpholine-2-carboxylate 2,2,2-trifluoroacetate
C8H12F3NO5 (259.06675379999996)
Methyl 6-methoxyformamido-4-chloropyridin-2-ylcarbamate
7-AMINO-1,8-NAPHTHYRIDIN-2(1H)-ONE SULFATE
C8H9N3O5S (259.02629040000005)
2-(3-aminophenyl)-1,1,1,3,3,3-hexafluoropropan-2-ol
2-Amino-5,6-dihydroxy-1,2,3,4-tetrahydronaphthalene hydrobromide
(4-chlorophenyl)(4-piperidyl)methanone hydrochloride
Benzaldehyde,4-[bis(2-chloroethyl)amino]-2-methyl-
2,6-dichloro-3-(2-chloroethyl)quinoline
C11H8Cl3N (258.97222980000004)
2,7-dichloro-3-(2-chloroethyl)quinoline
C11H8Cl3N (258.97222980000004)
8-chloro-1-oxido-5,6-dihydrobenzo[1,2]cyclohepta[2,4-b]pyridin-1-ium-11-one
2-oxo-1,3,4,5-tetrahydro-1-benzazepine-7-sulfonyl chloride
C10H10ClNO3S (259.00699000000003)
2-chloro-6-morpholin-4-yl-5-nitropyrimidin-4-amine
C8H10ClN5O3 (259.04721400000005)
2-(chloromethyl)-4-[(4-chlorophenyl)methyl]morpholine
2-Butenoic acid,4-[(3,4-dichlorophenyl)amino]-4-oxo-
5-(2,4-DICHLOROPHENYL)-4-METHYL-1,2,4-TRIAZOLE-3-THIOL
(1H-benzoimidazol-2-yl)-(4-chloro-6-methyl-pyrimidin-2-yl)-amine
ETHYL 5,7-DICHLOROPYRAZOLO[1,5-A]PYRIMIDINE-3-CARBOXYLATE
2-Benzimidazolecarbamic acid, 5,6-dichloro-, methyl ester
(4-Morpholinyl)acetic acid trifluoroacetic acid salt
C8H12F3NO5 (259.06675379999996)
methyl 5-chloroindeno[1,2-b]pyridine-5-carboxylate
2-(PHENYLTHIO)-PYRIDINE-4-CARBOXYLIC ACID ETHYL ESTER
C14H13NO2S (259.06669580000005)
N-[(4S,6S)-6-methyl-7,7-dioxo-5,6-dihydro-4H-thieno[2,3-b]thiopyran-4-yl]acetamide
1-(1H-imidazol-4-ylsulfonyl)piperidine-4-carboxylic acid
1-(1H-imidazol-4-ylsulfonyl)piperidine-3-carboxylic acid
3-Bromo-L-tyrosine
A bromoamino acid comprising an L-tyrosine core with a bromo- substituent ortho to the hydroxy group on the benzene ring.
Nicotinyl alcohol tartrate
C78274 - Agent Affecting Cardiovascular System > C29707 - Vasodilating Agent D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents
(3S,4R)-4-(2,5-dichlorophenyl)pyrrolidine-3-carboxylic acid
C11H11Cl2NO2 (259.01668060000003)
(3S,4R)-4-(2,3-dichlorophenyl)pyrrolidine-3-carboxylic acid
C11H11Cl2NO2 (259.01668060000003)
[2-[4-(trifluoromethyl)phenyl]-1,3-thiazol-4-yl]methanol
N-((4R,6S)-6-METHYL-7,7-DIOXIDO-5,6-DIHYDRO-4H-THIENO[2,3-B]THIOPYRAN-4-YL)ACETAMIDE
(5-Amino-2,3,4-trihydroxy-6-oxohexyl) dihydrogen phosphate
C6H14NO8P (259.04570140000004)
6-Fluoro-2-(2-methylphenyl)-1,2-benzothiazol-3-one
2H-1,4-Benzodiazepin-2-one, 7-chloro-1,3-dihydro-5-(1H-pyrrol-2-yl)-
3-Amino-4-chloro-N-(2-cyanoethyl)benzenesulfonamide
C9H10ClN3O2S (259.01822300000003)
5-(1-naphthalenylamino)-3H-1,3,4-thiadiazole-2-thione
2-[(2-Phenylethyl)thio]nicotinic acid
C14H13NO2S (259.06669580000005)
ML-099 (CID-888706) is a pan Ras-related GTPases activator that can activate Rac1, cell division cycle 42, Ras, Rab7, and Rab-2A[1].
Ethyl 2-(trifluoromethyl)imidazo[1,2-a]pyrimidine-3-carboxylate
2-[(3,4-Dimethylphenyl)sulfanyl]pyridine-3-carboxylic acid
C14H13NO2S (259.06669580000005)
N-(7-chloro-4-quinazolinyl)-N-(2-furylmethyl)amine
2-[(4-Methoxyphenyl)sulfonyl-methylamino]acetic acid
(3,4-Dihydroxy-2-nitrophenyl)(phenyl)methanone
D002491 - Central Nervous System Agents > D018726 - Anti-Dyskinesia Agents > D000978 - Antiparkinson Agents D004791 - Enzyme Inhibitors > D065098 - Catechol O-Methyltransferase Inhibitors
Sn-glycero-3-phosphoserine
C6H14NO8P (259.04570140000004)
A glycerol 1-phosphoserine in which the glycero portion has R-configuration.
Ethyl 4-nitrophenyl ethylphosphonate
D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D002800 - Cholinesterase Inhibitors D004791 - Enzyme Inhibitors Same as: D01591
[(2R,3S,4S,5R,6R)-3,4,5,6-tetrahydroxyoxan-2-yl]methyl sulfate
C6H11O9S- (259.01237760000004)
Glucosamine 6-Phosphate (closed ring, complete stereochemistry)
C6H14NO8P (259.04570140000004)
[(2R,3R,4R,5R,6S)-5-amino-3,4,6-trihydroxyoxan-2-yl]methyl dihydrogen phosphate
C6H14NO8P (259.04570140000004)
3-Amino-3-deoxy-beta-D-fructofuranose 6-phosphoric acid
C6H14NO8P (259.04570140000004)
(5-Methylsulfanylpentanethioylamino) hydrogen sulfate
1-Methyl-1,2,3,4-tetrahydroisoquinoline-6,7-diol hydrobromide
3-(methylthio)-5-[4-(trifluoromethyl)phenyl]-1H-1,2,4-triazole
N-(4-acetylphenyl)-2-thiophen-2-ylacetamide
C14H13NO2S (259.06669580000005)
(2r)-2-Azanyl-3-[(1r,2s)-2-Oxidanyl-1-Phosphono-Propyl]sulfanyl-Propanoic Acid
N-(3-acetylphenyl)-2-thiophen-2-ylacetamide
C14H13NO2S (259.06669580000005)
2-(4-Chlorophenyl)-5-(prop-2-enylamino)-4-oxazolecarbonitrile
2-(3-Chlorophenyl)-5-(prop-2-enylamino)-4-oxazolecarbonitrile
2-azaniumyl-2-deoxy-1-O-(hydroxyphosphinato)-alpha-D-galactopyranose
C6H14NO8P (259.04570140000004)
1-Amino-1-deoxy-scyllo-inositol 4-phosphate
C6H14NO8P (259.04570140000004)
O(4)-phosphonato-D-tyrosine(2-)
C9H10NO6P (259.02457300000003)
An optically active form of O(4)-phosphonatotyrosine(2-) having D-configuration.
4-amino-1-[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidine-2-thione
(5-Amino-3,4,6-trihydroxyoxan-2-yl)methyl dihydrogen phosphate
C6H14NO8P (259.04570140000004)
2-amino-2-deoxy-D-glucopyranose 6-phosphate
C6H14NO8P (259.04570140000004)
The pyranose form of D-glucosamine 6-phosphate.
aldehydo-D-glucosamine 6-phosphate
C6H14NO8P (259.04570140000004)
alpha-D-glucosamine 6-phosphate
C6H14NO8P (259.04570140000004)
A 2-amino-2-deoxy-D-glucopyranose 6-phosphate that has an alpha-configuration at the anomeric position.
glycerol 1-phosphoserine
C6H14NO8P (259.04570140000004)
A L-serine derivative consisting of L-serine having a 1-glycerophospho group attached to the side-chain hydroxy function.
O(4)-phosphonato-L-tyrosine(2-)
C9H10NO6P (259.02457300000003)
An optically active form of O(4)-phosphonatotyrosine(2-) having L-configuration.
(2E)-4-hydroxy-3-methylbut-2-enyl diphosphate(3-)
An organophosphate oxoanion that is the trianion of (2E)-4-hydroxy-3-methylbut-2-enyl diphosphate arising from deprotonation of the three OH groups of the diphosphate.
(5-amino-3,4,6-trihydroxyoxan-2-yl)methoxyphosphonic acid
C6H14NO8P (259.04570140000004)
5-(2-aminoethyl)-2-methoxy-3,4-bis(methylsulfanyl)phenol
C11H17NO2S2 (259.07006620000004)
20(S)-hydroxy-25-melhoxydainmar-23-en-3-one
{"Ingredient_id": "HBIN003508","Ingredient_name": "20(S)-hydroxy-25-melhoxydainmar-23-en-3-one","Alias": "NA","Ingredient_formula": "C13H9NO3S","Ingredient_Smile": "C1=CSC(=C1)C=CC(=O)C2=CC=C(C=C2)[N+](=O)[O-]","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "34518","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
[(2r,3s,4r,5r)-5-amino-3,4,6-trihydroxyoxan-2-yl]methoxyphosphonic acid
C6H14NO8P (259.04570140000004)
8-methoxy-4,12,14-trioxa-2-azatetracyclo[7.7.0.0³,⁷.0¹¹,¹⁵]hexadeca-1(16),2,5,7,9,11(15)-hexaen-16-ol
(methoxysulfanyl)({6-[(methoxysulfanyl)carbonyl]pyridin-2-yl})methanone
C9H9NO4S2 (258.99729940000003)
2-(2-bromo-6-hydroxy-3-methoxyphenyl)ethanimidic acid
2-[(3s,3ar)-7-chloro-3,3a-dihydroxy-3h-cyclopenta[a]inden-5-yl]acetonitrile
[(2r,3s,4r,5s,6r)-3-amino-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphosphonic acid
C6H14NO8P (259.04570140000004)